Business Loan and Security Agreement April 24, 2023Aditxt, Inc. • April 25th, 2023 • Pharmaceutical preparations • Delaware
This Business Loan and Security Agreement Supplement is part of (and incorporated by reference into) the Business Loan and Security Agreement. Borrower should keep this important legal document for Borrower's records.
UNSECURED PROMISSORY NOTEAditxt, Inc. • April 25th, 2023 • Pharmaceutical preparations • California
FOR VALUE RECEIVED, the undersigned, ADITXT, INC., a Delaware corporation (together with its successors and assigns, the “Borrower”), hereby promises to pay to the order of ______________, an individual (together with his successors and assigns, the “Lender”), at the Lender’s offices at 737 N. Fifth Street, Suite 200, Richmond, Virginia (or such other place as the Lender may designate in writing to the Borrower), the aggregate principal sum of ___________ dollars ($__________), with interest, upon the terms and subject to the conditions of this unsecured promissory note (the “Note”) as set forth below. The Lender and Borrower collectively shall be referred to as the “Parties.”
ASSET PURCHASE AGREEMENT by and among ADITXT, INC. and CELLVERA GLOBAL HOLDINGS LLC, CELLVERA DEVELOPMENT, LLC, CELLVERA HOLDINGS LTD, AIPHARMA GROUP LTD, CELLVERA LTD. and Alex Gadotti, in his capacity as Sellers’ Representative April 19, 2023Asset Purchase Agreement • April 25th, 2023 • Aditxt, Inc. • Pharmaceutical preparations • Delaware
This Asset Purchase Agreement (this “Agreement”) is made as of the commencement of business on the 19th day of April, 2023, by and among Aditxt, Inc., a Delaware corporation (the “Purchaser”), Cellvera Global Holdings LLC, a Delaware limited liability company (“DE Topco”), Cellvera Holdings Ltd., a company incorporated under the laws of the British Virgin Islands f/k/a AiPharma Holdings Limited (“BVI Holdco”), Cellvera Ltd, a company incorporated under the laws of the British Virgin Islands (“Cellvera Ltd”), Cellvera Development LLC, a Delaware limited liability company (“Cellvera Development” and together with DE Topco, BVI Holdco, Cellvera Ltd and Cellvera Development each a “Seller” and collectively, the “Sellers”), AiPharma Group Ltd., a Cayman Island corporation (the “Seller Owner”; and collectively with the Sellers “Cellvera”), Alex Gadotti, as the representative of Cellvera (in such capacity, the “Sellers’ Representative”). Capitalized terms not otherwise defined shall have the
